These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Optimal co-amoxiclav ratios for inhibiting Escherichia coli strains with different susceptibilities to the compounds. Gracia M; Ponte C; Soriano F Int J Antimicrob Agents; 2005 Apr; 25(4):352-3. PubMed ID: 15784320 [No Abstract] [Full Text] [Related]
25. New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review. Sánchez Navarro A Clin Pharmacokinet; 2005; 44(11):1097-115. PubMed ID: 16231964 [TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000. Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258 [TBL] [Abstract][Full Text] [Related]
27. Amoxicillin/clavulanic acid 2000mg/125mg extended release (XR): a review of its use in the treatment of respiratory tract infections in adults. McCormack PL; Keating GM Drugs; 2005; 65(1):121-36. PubMed ID: 15610061 [TBL] [Abstract][Full Text] [Related]
28. [The pharmacokinetics, dosage, tolerance, side effects and safety of the preparation Augmentin (a combination of amoxicillin and clavulanic acid)]. Robinson OP Antibiot Khimioter; 1992 Sep; 37(9):20-3. PubMed ID: 1444662 [No Abstract] [Full Text] [Related]
29. Extended release amoxicillin/clavulanate: optimizing a product for respiratory infections based on pharmacodynamic principles. Jacobs MR Expert Rev Anti Infect Ther; 2005 Jun; 3(3):353-60. PubMed ID: 15954852 [TBL] [Abstract][Full Text] [Related]
31. [The postantibiotic effect of amoxicillin/clavulanic acid on Streptococcus pneumoniae strains of different serotypes and penicillin sensitivity]. García Y; Gómez MJ; Ramos MC; Gómez-Lus ML; Prieto J Rev Esp Quimioter; 1998 Jun; 11(2):157-60. PubMed ID: 9795302 [TBL] [Abstract][Full Text] [Related]
32. Oral bioavailability and pharmacokinetic profile of the amoxicillin-clavulanic acid combination after intravenous and oral gavage administration in broiler chickens. Jerzsele A; Nagy G; Lehel J; Semjen G J Vet Pharmacol Ther; 2009 Oct; 32(5):506-9. PubMed ID: 19754920 [No Abstract] [Full Text] [Related]
33. Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens including a pharmacokinetically enhanced formulation. Löwdin E; Cars O; Odenholt I Clin Microbiol Infect; 2002 Oct; 8(10):646-53. PubMed ID: 12390283 [TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients. Carlier M; Noë M; De Waele JJ; Stove V; Verstraete AG; Lipman J; Roberts JA J Antimicrob Chemother; 2013 Nov; 68(11):2600-8. PubMed ID: 23800901 [TBL] [Abstract][Full Text] [Related]
35. [Study of the bactericide activity of the combination amoxycillin/clavulanic acid and its possible effects in the resistance of beta-lactam drugs]. Prieto J; Frías J; Alou L; Carcas A Med Clin (Barc); 1998 Feb; 110 Suppl 1():12-5. PubMed ID: 9717154 [No Abstract] [Full Text] [Related]
36. [Amoxicillin associated with clavulanic acid. Clinical efficacy and tolerance]. Lazzati M; Coppola D; Silvestri A; Introini L; Macchi R; Castoldi A Dent Cadmos; 1990 Mar; 58(5):40-8. PubMed ID: 2397838 [TBL] [Abstract][Full Text] [Related]
37. Amoxicillin/clavulanate for infections in infants and children: past, present and future. Klein JO Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S139-48. PubMed ID: 14567000 [TBL] [Abstract][Full Text] [Related]
38. Amoxicillin-clavulanic acid: additions and corrections. Ackerman BH; Wynne B Mayo Clin Proc; 1999 Oct; 74(10):1050-1. PubMed ID: 10918874 [No Abstract] [Full Text] [Related]
39. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage]. Fomina IP Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651 [No Abstract] [Full Text] [Related]
40. [Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model]. Gómez-Lus ML; García Y; Valero E; Amores R; Fuentes F Rev Esp Quimioter; 2000 Sep; 13(3):306-13. PubMed ID: 11086282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]